GAYLE KEIDER: Open Payments
NPI 1891971677 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$834 in 46 payments from 13 companies in 2025. Trend: 2023 $712 · 2024 $841 · 2025 $834
Food & beverage: $834
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $301 |
| GlaxoSmithKline, LLC. | 10 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Astellas Pharma US Inc | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Ozempic, Wegovy, TRELEGY ELLIPTA, SHINGRIX, MOUNJARO, BREZTRI, NURTEC ODT, VAXNEUVANCE.
Industry payments across MI — which companies pay providers there.
